論文

国際誌
2023年3月

Utility of a Physical Fitness Score in Screening for Chronic Diseases.

Journal of sports science & medicine
  • Takaaki Sato
  • Kazuya Fujihara
  • Mayuko Harada Yamada
  • Kaori Chou
  • Yuta Yaguchi
  • Masaru Kitazawa
  • Hajime Ishiguro
  • Taeko Osawa
  • Takaho Yamada
  • Satoru Kodama
  • Kiminori Kato
  • Hirohito Sone
  • 全て表示

22
1
開始ページ
98
終了ページ
110
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.52082/jssm.2023.98

We developed a new Physical Score (PS) consisting of comprehensive physical fitness indicators and elucidated the association between the resultant PS and metabolic diseases, i.e., diabetes, hypertension, dyslipidemia, fatty liver, and metabolic syndrome (MetS), among Japanese. Analyzed were 49,850 persons (30,039 men) aged 30 to 69 y who underwent physical fitness tests. Principal component analysis was performed on the correlation matrix of the physical fitness test results (relative grip strength, single-leg balance with eyes closed, and forward bending) according to sex and age. We defined the PS as the first principal component score. A formula was developed for various age groups comprised of men and women from 30 to 69 years of age from which the PS for each age and sex was calculated. The PS for both men and women was normally distributed with a value of 0 ± 1.15-1.16. Multivariate logistic regression analysis showed that the risk of metabolic diseases increased approximately 1.1-1.6 times per each 1-point reduction in the PS. The association between PS and MetS was particularly strong in that a 1-point reduction in the PS increased the risk of MetS by 1.54 times (95% confidence interval 1.46 to 1.62) in men and by 1.21 times (1.15 to 1.28) in women. The association between a lower PS and disease risk was stronger in younger men for fatty liver and in older men for MetS. Conversely, in women, the association between a lower PS and disease risk was stronger in older women for fatty liver and in younger women for MetS. For diabetes, hypertension, and dyslipidemia, the change in the impact of PS reductions across age groups was small. The PS is a useful and simple non-invasive tool for screening Japanese people for metabolic diseases.

リンク情報
DOI
https://doi.org/10.52082/jssm.2023.98
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/36876177
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982533
ID情報
  • DOI : 10.52082/jssm.2023.98
  • PubMed ID : 36876177
  • PubMed Central 記事ID : PMC9982533

エクスポート
BibTeX RIS